Life Technologies Corp. (LIFE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1600 FARADAY AVE CARLSBAD, CA 92008

Life Technologies is a global biotechnology tools company. Co. provides a range of products and services, including systems, instruments, reagents, and custom services. Co.'s portfolio of products includes technologies for capillary electrophoresis based sequencing, polymerase chain reaction, sample preparation, cell culture, ribonucleic acid interference analysis, functional genomics research, proteomics and cell biology applications, as well as clinical diagnostic applications, forensics, animal, food, pharmaceutical and water testing analysis. Co. operates its business under four divisions: Molecular Biology Systems; Genetic Systems; Cell Systems; and Mass Spectrometry.

Are you looking for these stocks instead?

View SEC Filings from LIFE instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Life Technologies Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding LIFE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LIFE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

UPRICHARD DAVID C

  • Director
 No longer subject to file 2014-02-03 0

HOFFMEISTER DAVID F CHIEF FINANCIAL OFFICER

  • Officer
 No longer subject to file 2014-02-03 0

LUCIER GREGORY T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 No longer subject to file 2014-02-03 0

COTTINGHAM JOHN A CHIEF LEGAL OFFICER

  • Officer
 No longer subject to file 2014-02-03 0

IYER BALAKRISHNAN S

  • Director
 No longer subject to file 2014-02-03 0

DITTAMORE RAYMOND V

  • Director
 No longer subject to file 2014-02-03 0

GRIMM DONALD W

  • Director
 No longer subject to file 2014-02-03 0

PETERSON PER A

  • Director
 No longer subject to file 2014-02-03 0

RICHARD KELLI CHIEF ACCOUNTING OFFICER

  • Officer
 No longer subject to file 2014-02-03 0

LEDDY PETER MICHAEL SVP, GLOBAL HUMAN RESOURCES

  • Officer
 No longer subject to file 2014-02-03 0

MATRICARIA RONALD A

  • Director
 No longer subject to file 2014-02-03 0

ADAM GEORGE F JR

  • Director
 No longer subject to file 2014-02-03 0

STEVENSON MARK PRESIDENT & COO

  • Officer
 No longer subject to file 2014-02-03 0

PESCOVITZ ORA H.

  • Director
 No longer subject to file 2014-02-03 0

ANDREWS RONALD ASBURY PRESIDENT, MEDICAL SCIENCES

  • Officer
 No longer subject to file 2014-02-03 0

MUNDIE CRAIG J

  • Director
 No longer subject to file 2014-02-03 0

LORIMIER BRADLEY G

  • Director
 No longer subject to file 2013-04-25 0

LEVINE ARNOLD J

  • Director
 No longer subject to file 2013-04-24 0

LONGFIELD WILLIAM H

  • Director
 No longer subject to file 2012-04-26 0

BRUST BERND PRESIDENT, MOLECULAR MEDICINE

  • Officer
 No longer subject to file 2011-05-02 0

BARTHELEMY NICOLAS PRES, COMMERCIAL OPERATIONS

  • Officer
 No longer subject to file 2011-05-02 0

MILLER JOHN L PRESIDENT, GENETIC SYSTEMS

  • Officer
 No longer subject to file 2011-05-02 0

GROSSMAN PAUL DAVID SVP, CORPORATE STRATEGY & DEV.

  • Officer
 No longer subject to file 2011-05-02 0

DANSKY PETER PRES, MOLECULAR BIOLOGY SYS

  • Officer
 No longer subject to file 2011-05-02 0

O'DONNELL MARK SEAN SVP, GLOBAL OPS & SERVICES

  • Officer
 No longer subject to file 2011-05-02 0

BEERY JOSEPH C SVP, CHIEF INFORMATION OFFICER

  • Officer
 No longer subject to file 2011-05-02 0

REYNOLDS W ANN

  • Director
 No longer subject to file 2011-04-28 0

SHANAHAN WILLIAM S

  • Director
 0 2010-04-29 0

BENCHIMOL CLAUDE SVP, ADVANCED GENOMIC SYSTEMS

  • Officer
 No longer subject to file 2008-11-21 0

SHORT JAY M PHD

  • Director
 No longer subject to file 2008-05-01 0

GIBSON KAREN CHIEF INFORMATION OFFICER

  • Officer
 No longer subject to file 2008-04-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments